Literature DB >> 31628648

Congestion occurrence and evaluation in acute heart failure scenario: time to reconsider different pathways of volume overload.

Alberto Palazzuoli1, Isabella Evangelista2, Ranuccio Nuti2.   

Abstract

Although congestion is considered to be the main reason for hospital admission in patients with acute heart failure, a simplistic view considering idro saline retention and total body volume accumulation did not provide convincing data. Clinical congestion occurrence is often the tip of the iceberg of several different mechanisms ranging from increased filling pressure to extravascular fluid accumulation and blood flow redistribution. Therefore, the clinical evaluation is often restricted to a simple physical examination including few and inaccurate signs and symptoms. This superficial approach has led to contradictory data and patients have not been evaluated according to a more realistic clinical scenario. The integration with new diagnostic ultrasonographic and laboratory tools would substantially improve these weaknesses. Indeed, congestion could be assessed by following the most recognized HF subtypes including primitive cardiac defect, presence of right ventricular dysfunction, and organ perfusion. Moreover, there is a tremendous gap regarding the interchangeable concept of fluid retention and redistribution used with a univocal meaning. Overall, congestion assessment should be revised, considering it as either central, peripheral, or both. In this review, we aim to provide different evidence regarding the concept of congestion starting from the most recognized pathophysiological mechanisms of AHF decompensation. We highlight the fact that a better knowledge of congestion is a challenge for future investigation and it could lead to significant advances in HF treatment.

Entities:  

Keywords:  Acute heart failure; Congestion; Echocardiography; Laboratory biomarkers

Mesh:

Substances:

Year:  2020        PMID: 31628648     DOI: 10.1007/s10741-019-09868-0

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  100 in total

1.  EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).

Authors:  Aldo P Maggioni; Ulf Dahlström; Gerasimos Filippatos; Ovidiu Chioncel; Marisa Crespo Leiro; Jaroslaw Drozdz; Friedrich Fruhwald; Lars Gullestad; Damien Logeart; Marco Metra; John Parissis; Hans Persson; Piotr Ponikowski; Mathias Rauchhaus; Adriaan Voors; Olav Wendelboe Nielsen; Faiez Zannad; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2010-08-29       Impact factor: 15.534

Review 2.  Mode of Death in Heart Failure With Preserved Ejection Fraction.

Authors:  Muthiah Vaduganathan; Ravi B Patel; Alexander Michel; Sanjiv J Shah; Michele Senni; Mihai Gheorghiade; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2017-02-07       Impact factor: 24.094

Review 3.  Decongestion in acute heart failure.

Authors:  Robert J Mentz; Keld Kjeldsen; Gian Paolo Rossi; Adriaan A Voors; John G F Cleland; Stefan D Anker; Mihai Gheorghiade; Mona Fiuzat; Patrick Rossignol; Faiez Zannad; Bertram Pitt; Christopher O'Connor; G Michael Felker
Journal:  Eur J Heart Fail       Date:  2014-03-05       Impact factor: 15.534

4.  Congestion in acute heart failure with reduced vs. preserved left ventricular ejection fraction: differences, similarities and remaining gaps.

Authors:  Vasiliki Bistola; Eftihia Polyzogopoulou; Ignatios Ikonomidis; John Parissis
Journal:  Eur J Heart Fail       Date:  2017-12-18       Impact factor: 15.534

5.  The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure.

Authors:  Johannes C Kelder; Maarten J Cramer; Jan van Wijngaarden; Rob van Tooren; Arend Mosterd; Karel G M Moons; Jan W Lammers; Martin R Cowie; Diederick E Grobbee; Arno W Hoes
Journal:  Circulation       Date:  2011-11-21       Impact factor: 29.690

6.  Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF.

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Matteo Beltrami; Ranuccio Nuti; John G Cleland
Journal:  Clin Res Cardiol       Date:  2018-03-12       Impact factor: 5.460

Review 7.  Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.

Authors:  Yen-Chun Lai; Longfei Wang; Mark T Gladwin
Journal:  J Physiol       Date:  2018-12-30       Impact factor: 5.182

8.  Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial.

Authors:  Martin Möckel; Julia Searle; Oliver Hartmann; Stefan D Anker; W Frank Peacock; Alan H B Wu; Alan Maisel; Anna Slagman; Jörn Ole Vollert; Jana Papassotiriou; Inder Anand; Robert Christenson; Lori B Daniels; Gerasimos S Filippatos; Christopher Hogan; Nils Morgenthaler; Christian Mueller; Sean-Xavier Neath; Leong Ng; Richard Nowak; Mark Richards; Salvatore Di Somma; Piotr Ponikowski
Journal:  Emerg Med J       Date:  2012-09-09       Impact factor: 2.740

9.  The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.

Authors:  Peter van der Meer; Douwe Postmus; Piotr Ponikowski; John G Cleland; Christopher M O'Connor; Gad Cotter; Marco Metra; Beth A Davison; Michael M Givertz; George A Mansoor; John R Teerlink; Barry M Massie; Hans L Hillege; Adriaan A Voors
Journal:  J Am Coll Cardiol       Date:  2013-03-14       Impact factor: 24.094

10.  Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function.

Authors:  Sean Balmain; Neal Padmanabhan; William R Ferrell; John J Morton; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2007-07-19       Impact factor: 15.534

View more
  7 in total

Review 1.  Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion.

Authors:  Michelle Hernandez; Ryan D Sullivan; Mariana E McCune; Guy L Reed; Inna P Gladysheva
Journal:  Diagnostics (Basel)       Date:  2022-04-14

Review 2.  Suppression of Cardiogenic Edema with Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction: Mechanisms and Insights from Pre-Clinical Studies.

Authors:  Ryan D Sullivan; Mariana E McCune; Michelle Hernandez; Guy L Reed; Inna P Gladysheva
Journal:  Biomedicines       Date:  2022-08-19

Review 3.  The interstitial compartment as a therapeutic target in heart failure.

Authors:  Doron Aronson
Journal:  Front Cardiovasc Med       Date:  2022-08-17

4.  Non-invasive assessment of acute heart failure by Stevenson classification: Does echocardiographic examination recognize different phenotypes?

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Serafina Valente; Andrea Stefanini; Erberto Carluccio; Giuseppe Ambrosio
Journal:  Front Cardiovasc Med       Date:  2022-09-27

Review 5.  Soluble CD146-an underreported novel biomarker of congestion: a comment on a review concerning congestion assessment and evaluation in acute heart failure.

Authors:  Justas Simonavičius; Aurimas Mikalauskas; Hans-Peter Brunner-La Rocca
Journal:  Heart Fail Rev       Date:  2021-05       Impact factor: 4.214

6.  Sex Differences in the Evaluation of Congestion Markers in Patients with Acute Heart Failure.

Authors:  Pietro Scicchitano; Claudio Paolillo; Micaela De Palo; Angela Potenza; Silvia Abruzzese; Marco Basile; Antonia Cannito; Maria Tangorra; Piero Guida; Pasquale Caldarola; Marco Matteo Ciccone; Francesco Massari
Journal:  J Cardiovasc Dev Dis       Date:  2022-02-24

7.  Clinical, Laboratory and Lung Ultrasound Assessment of Congestion in Patients with Acute Heart Failure.

Authors:  Alberto Palazzuoli; Isabella Evangelista; Matteo Beltrami; Filippo Pirrotta; Maria Cristina Tavera; Luigi Gennari; Gaetano Ruocco
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.